Rein Therapeutics Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 |
|---|---|---|---|
| Operating Activities | |||
| Net Income | $-22.6M | $-18.1M | $-12.9M |
| Depreciation & Amortization | $129.0K | $232.0K | $325.0K |
| Depreciation | — | — | — |
| Amortization | — | — | — |
| Stock-Based Compensation | $1.7M | $688.0K | $626.0K |
| Net Cash from Operating Activities | $-20.5M | $-15.0M | $-11.7M |
| Investing Activities | |||
| Capital Expenditures | $142.0K | — | $94.0K |
| Business Acquisitions | — | — | — |
| Net Cash from Investing Activities | $-38.9M | — | — |
| Financing Activities | |||
| Dividends Paid | — | — | — |
| Stock Repurchases | — | — | — |
| Net Cash from Financing Activities | $50.6M | — | — |
| Net Change in Cash | $-8.9M | $16.9M | $-2.4M |
| Free Cash Flow | $-20.7M | — | $-11.8M |